SARS-CoV-2 Variants and Global Population Vulnerability: Diagnostic Strategies, Vaccine Development, and Therapeutic Management

Vivek P. Chavda
Édition Vladimir N. Uversky
Passer aux renseignements sur les produits

SARS-CoV-2 Variants and Global Population Vulnerability: Diagnostic Strategies, Vaccine Development, and Therapeutic Management

Vivek P. Chavda
Édition Vladimir N. Uversky
Date de sortie :
Prix habituel $370.50
Prix promotionnel $370.50 Prix habituel
Vente ferme. Aucun retour ni échange.
La livraison de cet article sera effectuée sur rendez-vous par notre transporteur partenaire.
La livraison de cet article sera effectuée sur rendez-vous par notre transporteur partenaire.

Téléchargement numérique

Accès immédiat à votre bibliothèque Kobo

Livrer à

En stock en ligne. Expédition gratuite pour les commandes d’au moins 49 $

Acheter maintenant et ramasser en magasin Bay & Floor

Ramassage gratuit aujourd’hui

Trouver en magasin

En rupture de stock

Trouvé dans : Health, Medical Reference

Obtenez 1853 points plum  et profitez d’un rabais additionnel avec plum. En savoir plus

Afficher tous les renseignements

Aperçu

612 PAGESANGLAIS

Info promotionnelle
  • Date de publication : Jul 05, 2024
  • Langue : anglais
  • Nombre de pages : 612
  • Éditeur : Apple Academic Press
  • ISBN : 9781774917589
  • Dimensions : 6.13" W x 1.0" L x 9.19" H

Vivek P. Chavda, MPharm, is currently working as an Assistant Professor in the Department of Pharmaceutics and Pharmaceutical Technology at the L. M. College of Pharmacy, Ahmedabad, Gujarat, India. Before joining academia, he served in the biologics industry for almost eight years in research and development with two successful regulatory filings at Lupin Biotech (Pune) and Dr. Reddy's Laboratory (Hyderabad). He has more than 150 national and international publications, nearly 20 book chapters, several books, one patent in progress as well as numerous newsletter articles to his credit. His research interests include development of biologics processes and formulations, medical device development, nano-diagnostics, long-acting parenteral formulations, and nano-vaccines. He earned his BPharm and MPharm degrees (with gold medals) at Gujarat Technological University, Gujarat, India.

Vladimir N. Uversky, PhD, DSc, FRSB, FRSC

, is a full Professor in the Department of Molecular Biology, University of South Florida, Tampa, Florida, USA. Dr. Uversky works on various aspects of protein intrinsic disorder phenomenon and on analysis of protein folding and misfolding. He has authored over 1150 scientific publications. According to the Thomson Reuters' Web of Science, his work was cited over 66,000 times, and he has an h-index of 126. Dr. Uversky has been included in the prestigious Clarivate List of Highly Cited Researchers™ every year from 2014 to 2020. In 2021, he was elected as a Fellow of the Royal Society of Biology and a Fellow of the Royal Society of Chemistry. Over the years, he has delivered more than 240 invited talks at various national and international conferences and invited seminars in various universities and research institutions around the globe. Dr. Uversky has collaborated with more than 12,500 colleagues from more than 2,750 research organizations in 89 countries/territories. He is an editor of a number of scientific journals and has edited several books and book series on protein structure, function, folding, and misfolding. He obtained his PhD in Biophysics from the Moscow Institute of Physics and Technology and DSc in Biophysics from the Institute of Experimental and Theoretical Biophysics, Russian Academy of Sciences.

Articles récemment consultés